Retrospective Screening and Analysis of mcr-1 and blaNDM in Gram-Negative Bacteria in China, 2010–2019

Currently, Gram-negative bacteria have developed multidrug and broad-spectrum drug resistance, and the numbers of species and strains carrying mcr or blaNDM genes are increasing. In this study, mcr-1 and blaNDM distribution of 12,858 Gram-negative bacteria isolated from wildlife, patients, livestock...

Full description

Bibliographic Details
Main Authors: Rong Fan, Chuchu Li, Ran Duan, Shuai Qin, Junrong Liang, Meng Xiao, Dongyue Lv, Huaiqi Jing, Xin Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-02-01
Series:Frontiers in Microbiology
Subjects:
MCR
NDM
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2020.00121/full
id doaj-f312b9f160f448c5a783a8f653897e8e
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Rong Fan
Chuchu Li
Chuchu Li
Ran Duan
Shuai Qin
Junrong Liang
Meng Xiao
Dongyue Lv
Huaiqi Jing
Xin Wang
spellingShingle Rong Fan
Chuchu Li
Chuchu Li
Ran Duan
Shuai Qin
Junrong Liang
Meng Xiao
Dongyue Lv
Huaiqi Jing
Xin Wang
Retrospective Screening and Analysis of mcr-1 and blaNDM in Gram-Negative Bacteria in China, 2010–2019
Frontiers in Microbiology
MCR
NDM
polymyxin
carbapenem
Gram-negative
author_facet Rong Fan
Chuchu Li
Chuchu Li
Ran Duan
Shuai Qin
Junrong Liang
Meng Xiao
Dongyue Lv
Huaiqi Jing
Xin Wang
author_sort Rong Fan
title Retrospective Screening and Analysis of mcr-1 and blaNDM in Gram-Negative Bacteria in China, 2010–2019
title_short Retrospective Screening and Analysis of mcr-1 and blaNDM in Gram-Negative Bacteria in China, 2010–2019
title_full Retrospective Screening and Analysis of mcr-1 and blaNDM in Gram-Negative Bacteria in China, 2010–2019
title_fullStr Retrospective Screening and Analysis of mcr-1 and blaNDM in Gram-Negative Bacteria in China, 2010–2019
title_full_unstemmed Retrospective Screening and Analysis of mcr-1 and blaNDM in Gram-Negative Bacteria in China, 2010–2019
title_sort retrospective screening and analysis of mcr-1 and blandm in gram-negative bacteria in china, 2010–2019
publisher Frontiers Media S.A.
series Frontiers in Microbiology
issn 1664-302X
publishDate 2020-02-01
description Currently, Gram-negative bacteria have developed multidrug and broad-spectrum drug resistance, and the numbers of species and strains carrying mcr or blaNDM genes are increasing. In this study, mcr-1 and blaNDM distribution of 12,858 Gram-negative bacteria isolated from wildlife, patients, livestock, poultry and environment in 14 provinces of China from 2010 to 2019 and the antibiotics resistance in regard to polymyxins (polymyxin B and colistin) and carbapenems of positive strains were investigated. A total of 70 strains of 10 species carried the mcr-1 gene, positive rates of patients, livestock and poultry, and environmental strains were 0.62% (36/5,828), 4.07% (29/712), 5.43% (5/92), respectively. Six strains of 3 species carrying the blaNDM gene all came from patients 0.10% (6/5,828). Two new mcr-1 gene variants (GenBank: MK965883, MK965884) were identified, one of which contains premature stop codon. The drug susceptibility results showed that all mcr-1 carriers were sensitive to carbapenems, among which, 66 strains were resistant and 4 were sensitive to polymyxins. The strains with the blaNDM gene had different degrees of resistance to carbapenems and were sensitive to polymyxins. The findings that species carrying mcr-1 or blaNDM genes were limited and mostly normal flora of opportunistic or low pathogenic organisms indicated that transfer of mcr-1 and blaNDM genes between bacteria was relatively limited in China. The none detection among wildlife compared with other sources supports the speculation that the emergence of and increase in polymyxins and carbapenem-resistant strains was mainly related to the selective pressure of antibiotics.
topic MCR
NDM
polymyxin
carbapenem
Gram-negative
url https://www.frontiersin.org/article/10.3389/fmicb.2020.00121/full
work_keys_str_mv AT rongfan retrospectivescreeningandanalysisofmcr1andblandmingramnegativebacteriainchina20102019
AT chuchuli retrospectivescreeningandanalysisofmcr1andblandmingramnegativebacteriainchina20102019
AT chuchuli retrospectivescreeningandanalysisofmcr1andblandmingramnegativebacteriainchina20102019
AT randuan retrospectivescreeningandanalysisofmcr1andblandmingramnegativebacteriainchina20102019
AT shuaiqin retrospectivescreeningandanalysisofmcr1andblandmingramnegativebacteriainchina20102019
AT junrongliang retrospectivescreeningandanalysisofmcr1andblandmingramnegativebacteriainchina20102019
AT mengxiao retrospectivescreeningandanalysisofmcr1andblandmingramnegativebacteriainchina20102019
AT dongyuelv retrospectivescreeningandanalysisofmcr1andblandmingramnegativebacteriainchina20102019
AT huaiqijing retrospectivescreeningandanalysisofmcr1andblandmingramnegativebacteriainchina20102019
AT xinwang retrospectivescreeningandanalysisofmcr1andblandmingramnegativebacteriainchina20102019
_version_ 1724916575913377792
spelling doaj-f312b9f160f448c5a783a8f653897e8e2020-11-25T02:11:04ZengFrontiers Media S.A.Frontiers in Microbiology1664-302X2020-02-011110.3389/fmicb.2020.00121495541Retrospective Screening and Analysis of mcr-1 and blaNDM in Gram-Negative Bacteria in China, 2010–2019Rong Fan0Chuchu Li1Chuchu Li2Ran Duan3Shuai Qin4Junrong Liang5Meng Xiao6Dongyue Lv7Huaiqi Jing8Xin Wang9State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases – National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases – National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaDepartment of Acute Infectious Disease Control and Prevention, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases – National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases – National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases – National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases – National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases – National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases – National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaState Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases – National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, ChinaCurrently, Gram-negative bacteria have developed multidrug and broad-spectrum drug resistance, and the numbers of species and strains carrying mcr or blaNDM genes are increasing. In this study, mcr-1 and blaNDM distribution of 12,858 Gram-negative bacteria isolated from wildlife, patients, livestock, poultry and environment in 14 provinces of China from 2010 to 2019 and the antibiotics resistance in regard to polymyxins (polymyxin B and colistin) and carbapenems of positive strains were investigated. A total of 70 strains of 10 species carried the mcr-1 gene, positive rates of patients, livestock and poultry, and environmental strains were 0.62% (36/5,828), 4.07% (29/712), 5.43% (5/92), respectively. Six strains of 3 species carrying the blaNDM gene all came from patients 0.10% (6/5,828). Two new mcr-1 gene variants (GenBank: MK965883, MK965884) were identified, one of which contains premature stop codon. The drug susceptibility results showed that all mcr-1 carriers were sensitive to carbapenems, among which, 66 strains were resistant and 4 were sensitive to polymyxins. The strains with the blaNDM gene had different degrees of resistance to carbapenems and were sensitive to polymyxins. The findings that species carrying mcr-1 or blaNDM genes were limited and mostly normal flora of opportunistic or low pathogenic organisms indicated that transfer of mcr-1 and blaNDM genes between bacteria was relatively limited in China. The none detection among wildlife compared with other sources supports the speculation that the emergence of and increase in polymyxins and carbapenem-resistant strains was mainly related to the selective pressure of antibiotics.https://www.frontiersin.org/article/10.3389/fmicb.2020.00121/fullMCRNDMpolymyxincarbapenemGram-negative